ADC Therapeutics SAADCT

紐約證券 · USD
1.03
-0.29
(-21.97%)
收盤 06/06 03:59 (UTC+8)
盤後 
1.06 
+0.03 
(+2.91%)
06/06 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.17
  • 0.18
  • 0.17
  • 0.18
  • 0.17
  • 0.23
  • 0.19
  • 0.16
  • 0.23
  • 0.21
icon
  • 15.85
  • 7.52
  • -3.56
  • 6.05
  • -8.42
  • 36.21
  • -18.21
  • -12.80
  • 40.37
  • -9.57
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
20,851
23,058
16,427
18,839
23,033
16,910
18,464
17,410
18,053
16,790
營業成本
3,6151,6991,2028362,0611,3718511,2172,510254
營業毛利
17,236
21,359
15,225
18,003
20,972
15,539
17,613
16,193
15,543
16,536
營業費用
42,48139,27846,19462,15049,436--45,234-53,521
研發費用
19,87718,18426,80330,09028,92827,10132,50224,29525,73527,263
推銷及管理費用
22,60421,44219,01418,96920,50820,87420,67520,93923,42126,494
非經常性項目費用
--34837713,091------
其他營業費用
----------
營業利益
-25,245
-18,123
-30,969
-44,147
-28,464
-32,436
-35,564
-29,041
-33,613
-36,985
其他收入及費用
4,62624,1203,3951,7522,25713,3075,0626,007353-
利息費用
12,34913,01413,39212,99712,23011,91913,11712,67912,4967,675
稅前純益
-32,968
-6,813
-40,966
-55,392
-38,437
-31,048
-43,619
-35,713
-45,756
-34,111
所得稅
--404-1,254165-3219023416346,064
稅後純益
-32,968
-6,409
-40,966
-56,646
-38,602
-30,727
-43,969
-36,544
-46,606
-85,703
基本每股稅後盈餘(元)
-0.21-0.04-0.30-0.50-0.36-0.29-0.42-0.38-0.56-
稀釋每股稅後盈餘(元)
-0.210.02-0.28-0.50-0.36-0.27-0.42-0.37-0.56-
基本平均股數(千股)
154142.00150301.00136446.00113743.00107202.00105396.00104824.0095691.0082552.00-
稀釋平均股數(千股)
154142.00150301.00136446.00113743.00107202.00105396.00104824.0095691.0082552.00-
還原基本每股稅後盈餘(元)
-0.21-0.04-0.30-0.50-0.36-0.29-0.42-0.38-0.56-
還原稀釋每股稅後盈餘(元)
-0.210.02-0.28-0.50-0.36-0.27-0.42-0.37-0.56-
還原基本平均股數(千股)
154,142150,301136,446113,743107,202105,396104,82495,69182,552-
還原稀釋平均股數(千股)
154,142150,301136,446113,743107,202105,396104,82495,69182,552-
EBITDA(千元)
-13,44114,344-19,319-33,684-18,146-11,633-22,270-15,427-25,737-30,953

大家都在看

HOT